research-amylase.blogspot.com
HUMAN AMYLASE RESEARCH: December 2007
http://research-amylase.blogspot.com/2007_12_01_archive.html
Lipase and total amylase and its isoenzymes as markers of pancreatic injury in patients treated with antiepileptic drugs. Objective: The study of the serum lipase. And its isoenzymes as biochemical markers of pancreatic injury. In patients treated with valproic acid and other enzyme-inducing antiepileptic drugs. Method: The serum activities of lipase. Results: In the first group of patients a clinically significant difference in relation to the control group was not obtained for any of the enzyme. Conclu...
acid-phosphatase.blogspot.com
ACID PHOSPHATASE RESEARCH: Structural and functional analysis of human prostatic acid phosphatase
http://acid-phosphatase.blogspot.com/2010/09/structural-and-functional-analysis-of.html
Structural and functional analysis of human prostatic acid phosphatase. Prostatic acid phosphatase (PAP) is the most abundant phosphatase in human prostate tissue/secretions. PAP is a clinically important protein for its relevance as a biomarker of prostate carcinoma. Furthermore, it has a potential role in fertilization. We describe here most of the features of PAP including gene regulation, gene/protein structure, functions, its role in tumor progression and evolutionary features. Lee Biosolutions, Inc.
acid-phosphatase.blogspot.com
ACID PHOSPHATASE RESEARCH: Integration of immunotherapy into the management of advanced prostate cancer.
http://acid-phosphatase.blogspot.com/2012/10/integration-of-immunotherapy-into.html
Integration of immunotherapy into the management of advanced prostate cancer. ABSTRACT: Until recently, the only therapy shown to improve survival in men with metastatic castration-resistant prostate cancer (mCRPC) had been chemotherapy, usually reserved for symptomatic patients. However, sipuleucel-T, a cellular product directed toward a specific antigen, prostatic acid phosphatase. Posted by Diagnostic Research. Subscribe to: Post Comments (Atom). Non Prostatic Acid Phosphatase Protein.
acid-phosphatase.blogspot.com
ACID PHOSPHATASE RESEARCH: October 2012
http://acid-phosphatase.blogspot.com/2012_10_01_archive.html
Integration of immunotherapy into the management of advanced prostate cancer. ABSTRACT: Until recently, the only therapy shown to improve survival in men with metastatic castration-resistant prostate cancer (mCRPC) had been chemotherapy, usually reserved for symptomatic patients. However, sipuleucel-T, a cellular product directed toward a specific antigen, prostatic acid phosphatase. Posted by Diagnostic Research. Links to this post. Subscribe to: Posts (Atom). Non Prostatic Acid Phosphatase Protein.
acid-phosphatase.blogspot.com
ACID PHOSPHATASE RESEARCH: Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids
http://acid-phosphatase.blogspot.com/2009/08/glycomic-characterization-of-prostate.html
Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids. Prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) are glycoproteins secreted by prostate epithelial cells, and have a long clinical history of use as serum biomarkers of prostate cancers. White KY, Rodemich L, Nyalwidhe JO, Comunale MA, Clements MA, Lance RS, Schellhammer PF, Mehta AS, Semmes OJ, Drake RR. Posted by Diagnostic Research.
acid-phosphatase.blogspot.com
ACID PHOSPHATASE RESEARCH: June 2008
http://acid-phosphatase.blogspot.com/2008_06_01_archive.html
Significance of Serum Tartrate-Resistant Acid Phosphatase in Rheumatoid Arthritis. Abstract Human serum contains two related isoforms of tartrate-resistant acid phosphatase. Was determined by in-house immunoassay using commercial antibodies and CRP. Other commercial markers included bone-specific alkaline phosphatase (bALP), C-telopeptides of type-I collagen (ICTP), cartilage glycoprotein-39 (YKL-40), and IgM. Posted by Diagnostic Research. Links to this post. Posted by Diagnostic Research. Beta 2 Microg...
acid-phosphatase.blogspot.com
ACID PHOSPHATASE RESEARCH: May 2009
http://acid-phosphatase.blogspot.com/2009_05_01_archive.html
Prostatic acid phosphatase, a neglected ectonucleotidase. Two recent papers reveal that the soluble and secreted prostatic acid phosphatase, an enzyme that has long served as a diagnostic marker for prostate cancer, has a membrane-bound splice variant. This enzyme exhibits ecto-5'-nucleotidase activity, is widely distributed, and implicated in the formation of chronic pain. Institute of Cell Biology and Neuroscience, Biocenter, Goethe-University, 60438, Frankfurt, Germany,. Posted by Diagnostic Research.
acid-phosphatase.blogspot.com
ACID PHOSPHATASE RESEARCH: Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients
http://acid-phosphatase.blogspot.com/2011/05/serum-tartrate-resistant-acid.html
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients. The mean serum TRACP5b activities of Group I, Group II and normal subjects were 3.50 ± 2.23 U/l, 2.09 ± 0.72 U/l and 2.33 ± 0.52 U/l, respectively. After adjusting for age, stage, gender, and histology in a generalized linear model, Group I has significantly higher TRACP5b activity than Group II (p. Posted by Diagnostic Research. Subscribe to: Post Comments (Atom).
acid-phosphatase.blogspot.com
ACID PHOSPHATASE RESEARCH: November 2010
http://acid-phosphatase.blogspot.com/2010_11_01_archive.html
Serum Tartrate Resistant Acid Phosphatase as Prognostic Marker of Survival. Background: Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) activity is a marker of osteoclast number and is elevated in breast cancer (BC) patients with extensive bone metastasis, which might in turn reflect the tumour burden. We tested the hypothesis that baseline serum TRACP 5b activity and its interval change are potential prognostic markers of survival in BC patients with bone metastasis. Conclusions: We found that T...